Comprehensive Care Corporation, a leading behavioral health, substance abuse and pharmacy management services provider for employers, Taft-Hartley health and welfare Funds, and managed care companies throughout the U.S., today announced the signing of a Pharmacy Savings Management Agreement with Utica City School District.
[More]
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today financial results for the first quarter ended March 30, 2013.
[More]
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced financial results for the quarter ended March 31, 2013.
[More]
Yongye International, Inc., a leading developer, manufacturer, and distributor of crop nutrient products in the People's Republic of China, today announced its financial results for the quarter ended March 31, 2013.
[More]
Mitek Sports Medicine, a leading orthopaedics sports medicine company, announced the launch of the HEALIX™ 3.4mm Suture Anchor, the company's smallest dual-thread suture anchor for rotator cuff repair, and the launch of a new double-loaded minimally invasive partial thickness rotator cuff (PTRC) repair system, as part of its HEALIX TRANSTENDTM Implant System.
[More]
Gentiva Health Services, Inc., the largest provider of home health and hospice services in the United States based on revenue, today reported first quarter 2013 results.
[More]
Columbia Laboratories, Inc. today reported financial results for the three-month period ended March 31, 2013.
[More]
The CCIM Institute has accepted UT Dallas as a university partner, putting graduate students in real estate on the fast track to earning its prestigious expert designation.
[More]
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the first quarter ended March 31, 2013.
[More]
Good Start Genetics, Inc., an innovative molecular diagnostics company that has developed the new gold standard in carrier screening, today announced that it has closed a non-dilutive loan facility for up to $28 million of capital from Capital Royalty L.P.
[More]
Peripheral neuropathic pain is caused by lesion or disease to the peripheral somatosensory nervous system. Nerve damage that can lead to peripheral neuropathic pain can happen as a result of a range of different diseases, medications or traumatic injuries.
[More]
Handheld ultrasound device manufacturer Signostics has received a major boost with 510(k) clearance from the US Food and Drug Administration (FDA) to market its new Signos RT to the lucrative American market.
[More]
A new, cost-effective endoscopic option is now available to urologists. Physicians can use the Flexor® Vue™ Deflecting Endoscopic System during urological procedures to access and visualize body cavities or organs.
[More]
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported its financial results for the first quarter ended March 31, 2013.
[More]
Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2013. For the first quarter of 2013, Rigel reported a net loss of $25.6 million, or $0.29 per share, compared to a net loss of $23.2 million, or $0.32 per share, in the first quarter of 2012. Weighted average shares outstanding for the first quarters of 2013 and 2012 were 87.1 million and 71.4 million, respectively.
[More]
Perrigo Company today announced results for its third quarter ended March 30, 2013.Perrigo's Chairman and CEO Joseph C. Papa commented, "We are very pleased with our performance, as the team delivered all-time record quarterly revenue and adjusted diluted earnings per share.
[More]
Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.
[More]
BioCryst Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2013.
[More]
Akorn, Inc., a niche generic pharmaceutical company, today reported financial results for its first quarter ended March 31, 2013.
[More]
Clinical pathways and quality initiatives leading to world class outcomes are the foundation of a far-reaching agreement between New York-based Hospital for Special Surgery, the recognized leader in orthopedics, rheumatology and related specialties, and Amil Par, the largest managed healthcare organization in Brazil, on behalf of Hospitalys Ortopedia, its newly opened orthopedic center in Rio de Janeiro.
[More]